Eagle Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$22.8M Sell
299,707
-9,130
-3% -$686K 0.12% 173
2024
Q2
$22.1M Sell
308,837
-702,228
-69% -$51.7M 0.12% 167
2024
Q1
$70.2M Buy
1,011,065
+79,699
+9% +$5.7M 0.36% 104
2023
Q4
$71.9M Buy
931,366
+163,522
+21% +$10.8M 0.39% 103
2023
Q3
$52.3M Buy
767,844
+3,438
+0.4% +$272K 0.31% 120
2023
Q2
$62.4M Sell
764,406
-13,246
-2% -$1.06M 0.35% 111
2023
Q1
$57.7M Buy
777,652
+10,404
+1% +$802K 0.34% 104
2022
Q4
$63.3M Buy
767,248
+246,904
+47% +$19.6M 0.39% 100
2022
Q3
$36.9M Buy
520,344
+7,704
+2% +$666K 0.24% 132
2022
Q2
$44.4M Buy
512,640
+9,216
+2% +$864K 0.28% 122
2022
Q1
$54.5M Buy
503,424
+836
+0.2% +$86.3K 0.28% 124
2021
Q4
$63.9M Buy
502,588
+3,088
+0.6% +$379K 0.28% 132
2021
Q3
$60.5M Sell
499,500
-226,552
-31% -$27.6M 0.27% 139
2021
Q2
$81.7M Buy
726,052
+474,872
+189% +$50M 0.35% 112
2021
Q1
$24.4M Buy
251,180
+27,676
+12% +$2.52M 0.11% 222
2020
Q4
$17.7M Sell
223,504
-55,240
-20% -$4M 0.1% 231
2020
Q3
$17.2M Sell
278,744
-2,496
-0.9% -$162K 0.09% 226
2020
Q2
$17.8M Buy
281,240
+5,096
+2% +$305K 0.1% 225
2020
Q1
$13.1M Buy
276,144
+71,104
+35% +$3.56M 0.08% 242
2019
Q4
$11.3M Buy
205,040
+11,096
+6% +$582K 0.05% 294
2019
Q3
$9.49M Buy
193,944
+3,484
+2% +$175K 0.05% 321
2019
Q2
$9.93M Sell
190,460
-4,084
-2% -$206K 0.05% 311
2019
Q1
$9.66M Buy
194,544
+1,548
+0.8% +$69.7K 0.05% 306
2018
Q4
$6.98M Sell
192,996
-47,308
-20% -$1.98M 0.04% 332
2018
Q3
$12.3M Buy
240,304
+3,844
+2% +$170K 0.06% 314
2018
Q2
$8.75M Buy
236,460
+11,032
+5% +$421K 0.05% 343
2018
Q1
$8.51M Sell
225,428
-1,920
-0.8% -$67.8K 0.05% 337
2017
Q4
$7.44M Buy
227,348
+3,368
+2% +$107K 0.04% 365
2017
Q3
$6.87M Buy
223,980
+24,200
+12% +$718K 0.04% 385
2017
Q2
$5.87M Buy
199,780
+9,484
+5% +$259K 0.04% 405
2017
Q1
$4.83M Buy
190,296
+60,436
+47% +$1.56M 0.03% 427
2016
Q4
$3.34M Buy
129,860
+3,144
+2% +$82.6K 0.02% 477
2016
Q3
$3.47M Sell
126,716
-1,524
-1% -$41.9K 0.02% 473
2016
Q2
$3.62M Sell
128,240
-4,840
-4% -$124K 0.03% 459
2016
Q1
$3.14M Sell
133,080
-186,796
-58% -$4.11M 0.02% 484
2015
Q4
$7.2M Buy
319,876
+178,632
+126% +$4.07M 0.05% 368
2015
Q3
$3.26M Sell
141,244
-36,304
-20% -$910K 0.02% 482
2015
Q2
$4.37M Buy
177,548
+61,644
+53% +$1.54M 0.02% 459
2015
Q1
$2.91M Sell
115,904
-118,504
-51% -$2.82M 0.02% 490
2014
Q4
$5.41M Sell
234,408
-4,100
-2% -$93.8K 0.03% 409
2014
Q3
$5.58M Sell
238,508
-4,804
-2% -$113K 0.03% 412
2014
Q2
$5.63M Buy
243,312
+26,444
+12% +$584K 0.03% 435
2014
Q1
$4.63M Sell
216,868
-34,696
-14% -$781K 0.03% 489
2013
Q4
$5.95M Sell
251,564
-69,172
-22% -$1.5M 0.03% 401
2013
Q3
$6.43M Sell
320,736
-11,032
-3% -$209K 0.03% 440
2013
Q2
$5.73M Buy
+331,768
New +$5.51M 0.04% 429

Other funds holding TECH

Eagle Asset Management's TECH Position: Q3 2024 in Review

Eagle Asset Management reduced its Bio-Techne (TECH) stake by 3% in Q3 2024, selling an estimated $686K and leaving 299,707 shares worth $22.8M. The position accounts for 0.12% of the portfolio, ranked #173.

Eagle Asset Management first reported a position in TECH in Q2 2013 and has held it in 46 quarters since. The position peaked at $81.7M in Q2 2021. 561 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

  • Eagle Asset Management held 299,707 shares of Bio-Techne worth $22.8M as of Q3 2024.
  • Eagle Asset Management sold 9,130 Bio-Techne shares in Q3 2024, an estimated $686K.
  • Bio-Techne made up 0.12% of Eagle Asset Management's portfolio in Q3 2024, its #173 holding.
  • Eagle Asset Management first reported a position in Bio-Techne in Q2 2013 and has held it in 46 quarters since.
  • Eagle Asset Management's Bio-Techne position peaked at $81.7M in Q2 2021.
  • 561 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.